Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7083-0.0021 (-0.30%)
At close: 04:00PM EDT
0.7220 +0.01 (+1.93%)
After hours: 04:40PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-82,683
-113,724
-250,157
-65,578
-89,127
-
Depreciation & amortisation
6,402
6,243
6,629
5,947
6,578
-
Stock-based compensation
33,740
34,101
25,482
20,222
8,824
-
Change in working capital
-48,793
-58,977
-18,391
41,530
-23,197
-
Accounts receivable
-
0
0
9,387
-7,602
-
Inventory
-41,973
-29,647
0
0
-
-
Accounts payable
-6,178
-11,578
2,203
9,362
-1,159
-
Other working capital
-79,975
-125,329
-238,637
-2,878
-94,201
-
Other non-cash items
12,162
15,168
6,933
4,069
2,866
-
Net cash provided by operating activities
-76,006
-117,354
-228,816
6,688
-93,610
-
Cash flows from investing activities
Investments in property, plant and equipment
-3,969
-7,975
-9,821
-9,566
-591
-
Purchases of investments
0
-4,426
-48,221
-95,971
-218,284
-
Sales/maturities of investments
11,750
22,983
140,470
169,625
59,984
-
Net cash used for investing activities
7,781
10,582
82,428
64,088
-158,891
-
Cash flows from financing activities
Debt repayment
-
-52,860
-1,907
-948
0
-
Common stock issued
32,329
18,159
101,168
0
268,641
-
Common stock repurchased
-
-
-
-
0
0
Other financing activities
-
-
-
-
19,900
-425
Net cash used provided by (used for) financing activities
84,811
71,705
129,602
1,178
303,424
-
Net change in cash
16,586
-35,067
-16,786
71,954
50,923
-
Cash at beginning of period
103,026
171,215
188,002
116,049
65,126
-
Cash at end of period
119,612
136,150
171,215
188,002
116,049
-
Free cash flow
Operating cash flow
-76,006
-117,354
-228,816
6,688
-93,610
-
Capital expenditure
-3,969
-7,975
-9,821
-9,566
-591
-
Free cash flow
-79,975
-125,329
-238,637
-2,878
-94,201
-